Profil新闻

我们的专家

Lars Bochmann 博士

市场与业务发展执行总监

八月 19, 2025

Unlocking Biosimilar Insulins: Profil's Automated Clamps Lead the Way

The rise of biosimilar insulins has opened new opportunities for improving access to affordable diabetes care. Unlike small-molecule generics, biosimilars must prove their similarity through a

七月 9, 2025

Testing Procedure for Clinical Performance Evaluation of CGMs

Comparing the performance of different Continuous Glucose Monitoring (CGM) systems is challenging due to the lack of comprehensive guidelines for clinical study design. In particular, the absence of

六月 24, 2025

Measuring Vascular Health in Clinical Trials: Flow-Mediated Dilation

Introducing Flow-Mediated Dilation At Profil, we continuously innovate and apply the cutting-edge methods in our clinical research to better understand and treat metabolic diseases. One such method

六月 12, 2025

Studying Counterregulation with the Hypoglycemic Clamp

Introduction Hypoglycemic Clamp The hypoglycemic clamp is a gold-standard method for studying the body’s physiological response to low glucose levels. While often overshadowed by the more widely used

五月 29, 2025

Continuous Glucose Monitoring for Improved Glycaemic Assessment

Introduction CGM Continuous Glucose Monitoring (CGM) has emerged as an indispensable tool in both the management and investigation of metabolic diseases. For scientists engaged in clinical research,

五月 7, 2025

Advancing Liver Disease Research with Transient Elastography

Revolutionizing MASH and MASLD Clinical Trials with Transient Elastography At Profil, we're at the forefront of tackling metabolic diseases, focusing among others on Metabolic Associated Steatotic

四月 23, 2025

Advancing Early-Phase Clinical Trials with Automated Euglycemic Glucose Clamps

Advancing Diabetes & Metabolic Research with Fully Automated Glucose Clamps At Profil, we set the gold standard in clamp methodology with ClampArt®, our proprietary fully automated glucose clamp

四月 9, 2025

Exploring Metabolic Insights with Indirect Calorimetry

At Profil, our commitment to advancing metabolic health research is driven by our use of state-of-the-art technologies, such as Indirect Calorimetry. This highly accurate method is pivotal for

三月 25, 2025

The Evolving Landscape of GLP-1 Agonists: What’s New, What’s Next

GLP-1 receptor agonists have gained immense popularity for their effectiveness in weight management, shifting from a mere treatment for diabetes to some of the most sought-after weight-loss drugs.